NCT00907530View on ClinicalTrials.gov

Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain

PHASE4CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

July 31, 2011

Conditions
Brain Lesions
Interventions
DRUG

MULTIHANCE:

MULTIHANCE ® 0.5 M,0.1 mmol/kg

DRUG

GADOVIST

GADOVIST ® 1.0 M,0.1 mmol/kg

Trial Locations (1)

Unknown

Hamilton Health Sciences Corporation, Hamilton

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY